Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer

被引:23
作者
Bidard, F. -C. [1 ,2 ]
Ng, C. K. Y. [2 ]
Cottu, P. [1 ]
Piscuoglio, S. [2 ]
Escalup, L. [3 ]
Sakr, R. A. [4 ]
Reyal, F. [5 ]
Mariani, P. [5 ]
Lim, R. [2 ]
Wang, L. [2 ]
Norton, L. [6 ]
Servois, V. [7 ]
Sigal, B. [8 ]
Vincent-Salomon, A. [8 ]
Weigelt, B. [2 ]
Pierga, J. -Y. [1 ,9 ]
Reis-Filho, J. S. [2 ,10 ,11 ]
机构
[1] Inst Curie, Dept Med Oncol, F-75005 Paris, France
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Inst Curie, Dept Pharm, F-75005 Paris, France
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[5] Inst Curie, Dept Surg, F-75005 Paris, France
[6] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[7] Inst Curie, Dept Radiol, F-75005 Paris, France
[8] Inst Curie, Dept Pathol, F-75005 Paris, France
[9] Paris Descartes Univ, Paris, France
[10] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
[11] Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10021 USA
关键词
precision medicine; breast cancer; HER3; mutations; dual HER2 blockade; massively parallel sequencing; MUTATIONS; CARCINOMAS; AMPLICON;
D O I
10.1093/annonc/mdv217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: HER3 activating mutations have been shown in preclinical models to be oncogenic and ligand-independent, but to depend on kinase-active HER2. Patients and methods: Whole-exome sequencing of the primary HER2-negative breast cancer and its HER2-negative synchronous liver metastasis from a 46-year-old female revealed the presence of an activating and clonal HER3 G284R mutation. Results: HER2 dual blockade with trastuzumab and lapatinib as third-line therapy led to complete metabolic response in 2 weeks and confirmed radiological partial response after 8 weeks. Following the resection of the liver metastasis, the patient remains disease-free 40 weeks after initiation of the HER2 dual blockade therapy. Immunohistochemical analysis demonstrated a substantial reduction of phospho-rpS6 and phospho-AKT in the post-therapy biopsy of the liver metastasis. Discussion: This is the first-in-man evidence that anti-HER2 therapies are likely effective in breast cancers harboring HER3 activating mutations.
引用
收藏
页码:1704 / 1709
页数:7
相关论文
共 18 条
[1]   Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines [J].
Arriola, Edurne ;
Marchio, Caterina ;
Tan, David Sp ;
Drury, Suzanne C. ;
Lambros, Maryou B. ;
Natrajan, Rachael ;
Rodriguez-Pinilla, Socorro Maria ;
Mackay, Alan ;
Tamber, Narinder ;
Fenwick, Kerry ;
Jones, Chris ;
Dowsett, Mitch ;
Ashworth, Alan ;
Reis-Filho, Jorge S. .
LABORATORY INVESTIGATION, 2008, 88 (05) :491-503
[2]   Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data [J].
Bidard, Francois-Clement ;
Peeters, Dieter J. ;
Fehm, Tanja ;
Nole, Franco ;
Gisbert-Criado, Rafael ;
Mavroudis, Dimitrios ;
Grisanti, Salvatore ;
Generali, Daniele ;
Garcia-Saenz, Jose A. ;
Stebbing, Justin ;
Caldas, Carlos ;
Gazzaniga, Paola ;
Manso, Luis ;
Zamarchi, Rita ;
Fernandez de Lascoiti, Angela ;
De Mattos-Arruda, Leticia ;
Ignatiadis, Michail ;
Lebofsky, Ronald ;
van Laere, Steven J. ;
Meier-Stiegen, Franziska ;
Sandri, Maria-Teresa ;
Vidal-Martinez, Jose ;
Politaki, Eleni ;
Consoli, Francesca ;
Bottini, Alberto ;
Diaz-Rubio, Eduardo ;
Krell, Jonathan ;
Dawson, Sarah-Jane ;
Raimondi, Cristina ;
Rutten, Annemie ;
Janni, Wolfgang ;
Munzone, Elisabetta ;
Caranana, Vicente ;
Agelaki, Sofi A. ;
Almici, Camillo ;
Dirix, Luc ;
Solomayer, Erich-Franz ;
Zorzino, Laura ;
Johannes, Helene ;
Reis-Filho, Jorge S. ;
Pantel, Klaus ;
Pierga, Jean-Yves ;
Michiels, Stefan .
LANCET ONCOLOGY, 2014, 15 (04) :406-414
[3]   Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study [J].
Blackwell, Kimberly L. ;
Burstein, Harold J. ;
Storniolo, Anna Maria ;
Rugo, Hope S. ;
Sledge, George ;
Aktan, Gursel ;
Ellis, Catherine ;
Florance, Allison ;
Vukelja, Svetislava ;
Bischoff, Joachim ;
Baselga, Jose ;
O'Shaughnessy, Joyce .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2585-2592
[4]   Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer [J].
Bose, Ron ;
Kavuri, Shyam M. ;
Searleman, Adam C. ;
Shen, Wei ;
Shen, Dong ;
Koboldt, Daniel C. ;
Monsey, John ;
Goel, Nicholas ;
Aronson, Adam B. ;
Li, Shunqiang ;
Ma, Cynthia X. ;
Ding, Li ;
Mardis, Elaine R. ;
Ellis, Matthew J. .
CANCER DISCOVERY, 2013, 3 (02) :224-237
[5]   Absolute quantification of somatic DNA alterations in human cancer [J].
Carter, Scott L. ;
Cibulskis, Kristian ;
Helman, Elena ;
McKenna, Aaron ;
Shen, Hui ;
Zack, Travis ;
Laird, Peter W. ;
Onofrio, Robert C. ;
Winckler, Wendy ;
Weir, Barbara A. ;
Beroukhim, Rameen ;
Pellman, David ;
Levine, Douglas A. ;
Lander, Eric S. ;
Meyerson, Matthew ;
Getz, Gad .
NATURE BIOTECHNOLOGY, 2012, 30 (05) :413-+
[6]   Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma [J].
Daveau, C. ;
Baulies, S. ;
Lalloum, M. ;
Bollet, M. ;
Sigal-Zafrani, B. ;
Sastre, X. ;
Vincent-Salomon, A. ;
Tardivon, A. ;
Thibault, F. ;
Pierga, J. Y. ;
Cottu, P. ;
Sablin, M. P. ;
Rouzier, R. ;
Malhaire, C. ;
Mallon, P. ;
Reyal, F. .
BRITISH JOURNAL OF CANCER, 2014, 110 (09) :2195-2200
[7]   Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal [J].
Gao, Jianjiong ;
Aksoy, Buelent Arman ;
Dogrusoz, Ugur ;
Dresdner, Gideon ;
Gross, Benjamin ;
Sumer, S. Onur ;
Sun, Yichao ;
Jacobsen, Anders ;
Sinha, Rileen ;
Larsson, Erik ;
Cerami, Ethan ;
Sander, Chris ;
Schultz, Nikolaus .
SCIENCE SIGNALING, 2013, 6 (269) :pl1
[8]   Oncogenic ERBB3 Mutations in Human Cancers [J].
Jaiswal, Bijay S. ;
Kljavin, Noelyn M. ;
Stawiski, Eric W. ;
Chan, Emily ;
Parikh, Chaitali ;
Durinck, Steffen ;
Chaudhuri, Subhra ;
Pujara, Kanan ;
Guillory, Joseph ;
Edgar, Kyle A. ;
Janakiraman, Vasantharajan ;
Scholz, Rolf-Peter ;
Bowman, Krista K. ;
Lorenzo, Maria ;
Li, Hong ;
Wu, Jiansheng ;
Yuan, Wenlin ;
Peters, Brock A. ;
Kan, Zhengyan ;
Stinson, Jeremy ;
Mak, Michelle ;
Modrusan, Zora ;
Eigenbrot, Charles ;
Firestein, Ron ;
Stern, Howard M. ;
Rajalingam, Krishnaraj ;
Schaefer, Gabriele ;
Merchant, Mark A. ;
Sliwkowski, Mark X. ;
de Sauvage, Frederic J. ;
Seshagiri, Somasekar .
CANCER CELL, 2013, 23 (05) :603-617
[9]   Comprehensive molecular portraits of human breast tumours [J].
Koboldt, Daniel C. ;
Fulton, Robert S. ;
McLellan, Michael D. ;
Schmidt, Heather ;
Kalicki-Veizer, Joelle ;
McMichael, Joshua F. ;
Fulton, Lucinda L. ;
Dooling, David J. ;
Ding, Li ;
Mardis, Elaine R. ;
Wilson, Richard K. ;
Ally, Adrian ;
Balasundaram, Miruna ;
Butterfield, Yaron S. N. ;
Carlsen, Rebecca ;
Carter, Candace ;
Chu, Andy ;
Chuah, Eric ;
Chun, Hye-Jung E. ;
Coope, Robin J. N. ;
Dhalla, Noreen ;
Guin, Ranabir ;
Hirst, Carrie ;
Hirst, Martin ;
Holt, Robert A. ;
Lee, Darlene ;
Li, Haiyan I. ;
Mayo, Michael ;
Moore, Richard A. ;
Mungall, Andrew J. ;
Pleasance, Erin ;
Robertson, A. Gordon ;
Schein, Jacqueline E. ;
Shafiei, Arash ;
Sipahimalani, Payal ;
Slobodan, Jared R. ;
Stoll, Dominik ;
Tam, Angela ;
Thiessen, Nina ;
Varhol, Richard J. ;
Wye, Natasja ;
Zeng, Thomas ;
Zhao, Yongjun ;
Birol, Inanc ;
Jones, Steven J. M. ;
Marra, Marco A. ;
Cherniack, Andrew D. ;
Saksena, Gordon ;
Onofrio, Robert C. ;
Pho, Nam H. .
NATURE, 2012, 490 (7418) :61-70
[10]   Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia [J].
Landau, Dan A. ;
Carter, Scott L. ;
Stojanov, Petar ;
McKenna, Aaron ;
Stevenson, Kristen ;
Lawrence, Michael S. ;
Sougnez, Carrie ;
Stewart, Chip ;
Sivachenko, Andrey ;
Wang, Lili ;
Wan, Youzhong ;
Zhang, Wandi ;
Shukla, Sachet A. ;
Vartanov, Alexander ;
Fernandes, Stacey M. ;
Saksena, Gordon ;
Cibulskis, Kristian ;
Tesar, Bethany ;
Gabriel, Stacey ;
Hacohen, Nir ;
Meyerson, Matthew ;
Lander, Eric S. ;
Neuberg, Donna ;
Brown, Jennifer R. ;
Getz, Gad ;
Wu, Catherine J. .
CELL, 2013, 152 (04) :714-726